Bioequivalence standards for generic drugs have long ignored batch-to-batch variability, risking false conclusions. New guidelines now require multi-batch testing to ensure real-world equivalence and patient safety.
Dec, 5 2025
Jan, 11 2026
Nov, 18 2025
Oct, 10 2025
Oct, 24 2025